维也纳消息:在第ⅩⅢ届国际化疗会议上报告的一组临床试验表明,一种新的第三代头孢菌素能治疗对抗生素抗药的绿脓杆菌和其它难以治疗的革兰氏阴性菌得到很好的成绩。这种被称为Ceftazidime的新药,能高度有效地抗重病患者在医院获得的难治性呼吸系和泌尿系感染,并可望治疗囊性纤维变性病人常患的感染。譬如,波特兰缅因医学中心 VIENNA: A group of clinical trials reported at the XIII International Conference on Chemotherapy showed that a new third-generation cephalosporin is able to treat antibiotic-resistant Pseudomonas aeruginosa and other intractable Gram-negative bacteria Very good result. The new drug, known as Ceftazidime, is highly effective against refractory respiratory and urinary infections acquired at hospitals in seriously ill patients and is expected to treat infections often associated with patients with cystic fibrosis. For example, Portland Maine Medical Center